FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: CVSI

  • Home
  •  | 
  • Tag Archives: "CVSI"

CV Sciences, Inc. Engages ICR to Enhance Investor Relations and Corporate Communications

CV Sciences, Inc. Engages ICR to Enhance Investor Relations and Corporate Communications
Feb. 05, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp CBD products through its industry-dominating brand PlusCBD Oil™, today announced that it has engaged ICR, a leading strategic communications and advisory firm, to enhance the Company’s investor relations, media relations and corporate communications program.
Read more

Leading Investment Newsletter Ranks GreenGro Technologies as 10th Most Attractive Stock to Own Out of List of 30 Other Cannabis Securities

Leading Investment Newsletter Ranks GreenGro Technologies as 10th Most Attractive Stock to Own Out of List of 30 Other Cannabis Securities
Cannabidiol, or CBD, is a component of the marijuana plant. Unlike THC, CBD cannot give you a sense of euphoria or make you intoxicated.  What it can do, however, is provide anti-inflammatory, analgesic, anti-nausea and anti-seizure effects, according to industry experts.  While THC acts on certain cannabinoid receptors found in the brain and central nervous system, CBD works throughout the body.  GreenGro’s strategy all along was to allow the heavyweights, such as GW Pharmaceuticals and Insys Therapeutics, Inc. to spend the millions of research and development dollars it did not have to create the market for smaller yet more agile players such as GreenGro Technologies.  The Company expects to update investors on its latest developments in this arena very shortly.
Read more

CV Sciences, Inc. Repays Remaining Debt

CV Sciences, Inc. Repays Remaining Debt
CV Sciences, Inc. Repays Remaining Debt LAS VEGAS, Aug. 22, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced today that it has fully repaid the promissory note payable (“Promissory Note”) to Wiltshire, LLC in cash, thus avoiding any remaining interest payments due on the Note. The Company issued…
Read more

CV Sciences, Inc. Pre-Announces Record Second Quarter 2018 Sales

CV Sciences, Inc. Pre-Announces Record Second Quarter 2018 Sales
CV Sciences, Inc. (OTCQB:CVSI) (the “Company,” “CV Sciences,” “our” or “we”), preeminent supplier and manufacturer of hemp-based phytocannabinoids including cannabidiol (CBD) oil and developer of specialty pharmaceutical therapeutics, today announced unaudited second quarter 2018 revenue and selected business highlights for the quarter ended June 30, 2018.
Read more